Vitiligo associated with malignant melanoma and lupus erythematosus

Journal of Dermatology

Volumn 34, Issue 2, 2007, Pages 142-145

  Gül, Ülker ^a   Kiliç, Arzu ^a,c   Tulunay, Özden ^b   Kaygusuz, Gülşah ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Lupus erythematosus; Melanoma; Urticaria; Vitiligo

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINUCLEAR ANTIBODY; HYDROXYCHLOROQUINE;

ADULT; ARTICLE; ATOPY; AXILLA; BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LUPUS ERYTHEMATOSUS; LYMPHADENOPATHY; MELANOMA; METASTASIS; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; RASH; THORAX; URTICARIA; VITILIGO;

FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, DISCOID; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; VITILIGO;

EID: 33846220267     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2006.00235.x     Document Type: Article

References (20)

1. Berd D, Mastrangelo MJ, Lattime E et al. Melanoma and vitiligo: immunology's Grecian urn, Cancer Immunol Immnother 1996; 42: 263-267.
2. Cavallari V, Cannavo SP, Ussia AF. Vitiligo associated with metastatic malignant melanoma, Int J Dermatol 1996; 35: 738-740.
3. Kovacs OS. Vitiligo J Am Acad Dermatol 1998; 38: 647-646.
4. Callen JP. Discoid lupus erythematosus in a patient with vitiligo and autoimmune thyroiditis, Int J Dermatol 1984; 23: 203-241.
5. Forestier JY, Ortonne JP, Thiovolet L et al. Lupus erythemateux et vitiligo. Ann Dermatol Venereol 1981; 108: 33-35.
6. Matarredona J, Sendagorta E, Rocamora A, Orofino L, Ledo A. Systemic lupus erythematosus appearing as an urticarial vasculitis. Int J Dermatol 1986; 25: 446-448.
7. Soter AN, Kaplan AP. Urticaria and Angioedema. In: Freedberg IM, Eisen AZ, Austen KF, Goldsmith LA, Katz SI. Dermatology in General Medicine. 6th edn. New York, McGraw-Hill, 2003; 1129-1139.
8. Terr AI. Anaphylaxis and Urticaria. In: Stites DP, Terr AI, Parslow TG. Medical Immunology. 9th edn. Prentice-Hall International, New York, 1997: 409-418.
9. Ortonne J-P, Bahadoran P, Fitzpatrick TB, Mosher DB, Hori Y. Hypomelanoses and Hypermelanoses. In: Freedberg IW, Eisen AZ, Austen KF, Goldsmith LA, Katz SI. Dermatology in General Medicine, 6th edn. McGraw-Hill, New York, 2003: 836-881.
10. Liu JB, Li M, Yang S et al. Clinical profiles of vitiligo in China: an analysis of 3472 patients. Clin Exp Dermatol 2005; 30: 372-331.
11. Kawakami Y, Suzuki Y, Shofuda T et al. T cell immune responses against melanoma and melanocytes in cancer and autoimmunity. Pigment Cell Res 2000; 13: 163-169.
12. Kalinska-Wankowicz A, Le Poole C, Van Den Wijngaard R, Storkus WJ, Das PK. Melanocyte-specific immune response in melanoma and vitiligo: two faces of the same coin? Pigment Cell Res 2003; 16: 254-260.
13. Bystryn J-C, Rigel D, Friedman RJ, Kopf A. Prognostic significance of hypopigmentation in malignant melanoma. Arch Dermatol 1997; 123: 1053-1056.
14. Nordlund JJ, Kirkwood JM, Forget BM et al. Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 1983; 9: 689-691.
15. Schallreuter KU, Levening C, Berger J. Vitiligo and cutaneous melanoma. Dermatologica 1991; 183: 239-241.
16. Sulkes A, Naparstek Y. The infrequent association of systemic lupus erythematosus and solid tumours, Cancer 1991; 68: 1389-1391.
17. Modly C, Wood C, Horn T. Metastatic malignant melanoma arising from a common blue nevus in a patient with subacute cutaneous lupus erythematosus. Dermatologica 1989; 178: 171-175.
18. Baker RJ. Johnson WD. Discoid lupus erthematosus resembling vitiligo. Cutis 1971; 7: 667-669.
19. Davis MDP, Brewer JD. Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin N Am 2004; 24: 183-213.
20. Yell JA, Mbuagbaw J, Burge SM. Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol 1996; 135: 355-362.